2408123-36-2

2408123-36-2 structure
2408123-36-2 structure
  • Name: HDAC-IN-38
  • Chemical Name: HDAC-IN-38
  • CAS Number: 2408123-36-2
  • Molecular Formula: C27H28ClN3O2
  • Molecular Weight: 461.98
  • Catalog: Signaling Pathways Cell Cycle/DNA Damage HDAC
  • Create Date: 2022-07-29 18:45:27
  • Modify Date: 2024-09-19 14:15:04
  • HDAC-IN-38 (compound 13) is a potent HDAC inhibitor. HDAC-IN-38 shows similar micro-molar inhibitory activity toward HDAC1, 2, 3, 5, 6, and 8. HDAC-IN-38 increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy. HDAC-IN-38 also increases the level of histone acetylation (H3K14 or H4K5)[1].

Name HDAC-IN-38
Description HDAC-IN-38 (compound 13) is a potent HDAC inhibitor. HDAC-IN-38 shows similar micro-molar inhibitory activity toward HDAC1, 2, 3, 5, 6, and 8. HDAC-IN-38 increases cerebral blood flow (CBF), attenuates cognitive impairment, and improves hippocampal atrophy. HDAC-IN-38 also increases the level of histone acetylation (H3K14 or H4K5)[1].
Related Catalog
Target

HDAC8:0.533 μM (IC50)

HDAC6:1.27 μM (IC50)

HDAC3:2.86 μM (IC50)

HDAC1:3.82 μM (IC50)

HDAC5:6.27 μM (IC50)

HDAC2:6.62 μM (IC50)

References

[1]. Kaur N, et al. Protective effects of 10,11-dihydro-5H-dibenzo[b,f]azepine hydroxamates on vascular cognitive impairment. Eur J Med Chem. 2020 Feb 1;187:111915.

Molecular Formula C27H28ClN3O2
Molecular Weight 461.98